Widespread urticaria due to intramuscular interferon beta-1a therapy for multiple sclerosis [artículo]
Por: Benito León, Julián [Neurología]
| Bermejo Pareja, Félix [Neurología] | Guijarro Castro, Cristina [Neurología].
Colaborador(es): Servicio de Neurología-Neurofisiología.
Editor: Neurological Sciences, 2011Descripción: 32(2):309-311.Recursos en línea: Solicitar documento Resumen: We describe two multiple sclerosis patients who displayed widespread urticaria due to intramuscular interferon beta-1a (INF-beta-1a). Clinicians should be aware of this adverse event, since it may be severe and it may lead to the definitive interruption of treatment. Widespread urticaria complicating intramuscular INF-beta-1a therapy in multiple sclerosis should be therefore added to the list of dermatological lesions associated with interferon therapy.
| Tipo de ítem | Ubicación actual | Signatura | Estado | Fecha de vencimiento |
|---|---|---|---|---|
Artículo
|
PC5763 (Navegar estantería) | Disponible |
Formato Vancouver:
Guijarro C, Benito-León J, Bermejo-Pareja F. Widespread urticaria due to intramuscular interferon beta-1a therapy for multiple sclerosis. Neurol Sci. 2011 Apr;32(2):309-11.
PMID:20890624
Contiene 9 referencias
We describe two multiple sclerosis patients who displayed widespread urticaria due to intramuscular interferon beta-1a (INF-beta-1a). Clinicians should be aware of this adverse event, since it may be severe and it may lead to the definitive interruption of treatment. Widespread urticaria complicating intramuscular INF-beta-1a therapy in multiple sclerosis should be therefore added to the list of dermatological lesions associated with interferon therapy.
No hay comentarios para este ejemplar.